1
|
Qin SB, Gao XS, Yu W, Zhang CJ, Hao H, Yao L, Bai Y, Li HZ, He ZS, Wang D. Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys 2023; 117:S111. [PMID: 37784292 DOI: 10.1016/j.ijrobp.2023.06.438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Previous studies showed that selective bladder-sparing approach using TMT is an established therapy of MIBC with outcomes that are comparable to those of radical cystectomy. However, it has been shown that the 5-year local recurrence in the bladder is greater than 40% after TMT. One of the possible reasons was that the RT dose to the bladder tumor or tumor bed was insufficient. Thus, we assessed the effectiveness and safety of Stereotactic Ablative Radiotherapy (SABR) boost to bladder tumor or tumor bed for patients with muscle invasive bladder cancer (MIBC). MATERIALS/METHODS A total of 59 consecutive patients with cT2-4 bladder cancer underwent transurethral resection of bladder tumor (TURBT). TURBT was visibly complete in 25 cases. Patients received SABR to the tumor or tumor bed in the bladder followed by conventionally fractionated RT (CFRT) to pelvis and total bladder with concomitant weekly radio-sensitizing chemotherapy. During SABR intravesical installation of isovolumetric saline through urinary catheter ensured adequate bladder filling. Response rate was assessed by cystoscopic evaluation and pelvic MRI or CT. Toxicities were reported per the RTOG acute and late Radiation Morbidity Scoring Schema. RESULTS The median age of all patients was 76 years (35-90 years). All patients completed SBRT boost and 61% patients received concurrent Gemcitabine chemotherapy. After a median follow-up time of 28 months, the rate of local control (LC) at 3 years was 90.0%. The overall survival (OS) and cancer-specific survival (CSS) rates at 3 years were 61.6% and 77.5%, respectively. Of the surviving patients, 84.4% have a disease-free and functioning bladder. Acute grade 3 gastrointestinal (GI) or genitourinary (GU) toxicities occurred in only 1.7% of the patients. Late grade 3 GU toxicity occurred in 5.1% of the patients. No patients experienced grade 4 GI or GU toxicities. CONCLUSION SABR boost followed by chemoradiation to the pelvis was found to be a well-tolerated and effective treatment for MIBC patients who are either not candidates for cystectomy or who desire bladder preservation. Randomized study is required to further evaluate this novel tri-modality treatment paradigm.
Collapse
Affiliation(s)
- S B Qin
- Department of Radiation Oncology, Peking University First Hospital, Beijing, China
| | - X S Gao
- Department of Radiation Oncology, Peking University First Hospital, Beijing, China
| | - W Yu
- Department of Urology, Peking University First Hospital, Beijing, China
| | - C J Zhang
- Department of Urology, Peking University First Hospital, Beijing, China
| | - H Hao
- Department of Urology, Peking University First Hospital, Beijing, China
| | - L Yao
- Department of Urology, Peking University First Hospital, Beijing, China
| | - Y Bai
- Department of Radiation Oncology, Peking University First Hospital, Beijing, China
| | - H Z Li
- Department of Radiation Oncology, Peking University First Hospital, Beijing, China
| | - Z S He
- Department of Urology, Peking University First Hospital, Beijing, China
| | - D Wang
- Rush University Medical Center, Chicago, IL
| |
Collapse
|
2
|
Tian CW, Zhu HY, Zhou J, Bai LY, Wu W, Qin SB, Gao W, Shi L, Chen XX, Xie T, Chen H, Rui YF. [Effect of Friday surgery on clinical outcome of elderly patients with hip fracture under multidisciplinary treatment]. Zhonghua Yi Xue Za Zhi 2023; 103:1496-1503. [PMID: 37198113 DOI: 10.3760/cma.j.cn112137-20221024-02216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/19/2023]
Abstract
Objective: To assess the impact of Friday surgery on clinical outcomes in elderly patients with hip fracture under multidisciplinary treatment. Methods: A retrospective cohort study. The clinical data of 414 geriatric patients with hip fractures admitted to Zhongda Hospital Affiliated with Southeast University from January 2018 to March 2021 were analyzed retrospectively, including 126 males and 288 females with a mean age of (81.3±7.6) years. The patients were divided into two groups based on whether they underwent surgery on Friday or not. The Friday group(n=69) and the non-Friday group(n=345) were compared in terms of general information, American Society of Anesthesiologists(ASA) classification, fracture type, injury to admission time, preoperative waiting time, surgical method, anesthesia type and use of intensive care unit (ICU) fast track. Propensity score matching (PSM) was performed based on age, ASA grade, time from injury to admission, preoperative waiting time, hemoglobin and albumin levels at admission. Clinical outcomes were collected and compared between the two groups, including length of hospital stay, total hospitalization cost and 30-day, 90-day and 1-year mortality rates, and postoperative complications. Multivariate logistic regression analyses were conducted to identify influencing factors for 1-year mortality in geriatric patients with hip fracture. Results: Baseline data showed statistically significant differences in hemoglobin, albumin and preoperative waiting time between the two groups (all P<0.05). After PSM matching, 69 patients were included in each group, and no significant differences were observed in baseline data between the two groups (all P>0.05). There was no significant differences in 30-day mortality rate (4.3% vs 0, P=0.080), 90-day mortality rate (7.2% vs 1.4%, P=0.095), length of hospital stay [(10.85±4.45)d vs (10.92±3.68)d, P=0.919], total hospitalization cost [(60.9±15.4) thousands yuan vs (59.1±15.4) thousands yuan, P=0.489], postoperative complications [pneumonia (11.6% vs 13.0%, P=0.796), cardio-cerebrovascular complications (11.6% vs 8.7%, P=0.573) and delirium (5.7% vs 2.9%, P=0.245)] between the Friday group and the non-Friday group (all P>0.05). However, the 1-year mortality rate was higher in the Friday group than that in the non-Friday group(18.8% vs 4.3%, P=0.008). Multivariate analysis revealed that surgery on Friday (OR=11.222, 95%CI: 2.198-57.291, P=0.004), low hemoglobin levels at admission (OR=0.920, 95%CI: 0.875-0.967, P=0.001), hemiarthroplasty treatment (OR=5.127, 95%CI: 1.308-20.095, P=0.019) and longer surgery duration (OR=0.958, 95%CI: 0.927-0.989, P=0.009) were influencing factors for 1-year mortality in geriatric patients with hip fracture. Conclusions: In the context of multidisciplinary treatment, Friday surgery does not increase short-term mortality, length of hospital stay, total hospitalization cost or incidence of complications in geriatric patients with hip fracture. However, it remains a influencing factor for 1-year mortality in those patients.
Collapse
Affiliation(s)
- C W Tian
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - H Y Zhu
- School of Medicine, Southeast University, Nanjing 210009, China
| | - J Zhou
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - L Y Bai
- Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - W Wu
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - S B Qin
- School of Medicine, Southeast University, Nanjing 210009, China
| | - W Gao
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - L Shi
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - X X Chen
- Trauma Center, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - T Xie
- Trauma Center, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - H Chen
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| | - Y F Rui
- Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
| |
Collapse
|
3
|
Wang LL, Qin SB, Xu XT, Hu C, Qian DQ, Ye C, Zhou JY. [Killing effect and its mechanism of low-temperature plasma on different human cancer cell lines]. Zhonghua Zhong Liu Za Zhi 2017; 38:725-730. [PMID: 27784453 DOI: 10.3760/cma.j.issn.0253-3766.2016.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the killing effect of low-temperature plasma (LTP) on HepG2, A549 and HeLa cell lines and explore its possible mechanism. Methods: The inhibitory effect of LTP on the proliferation of HepG2, A549 and HeLa cells was determined by MTT assay. Transmission electron microscopy was used to observe the ultrastructural changes of HepG2, A549 and HeLa cells treated with LTP. Cell apoptosis was detected by Muse cytometry. Western blot was used to detect the expression of apoptosis-related proteins. Results: The survival rates of LTP-irradiated HepG2 cells (irradiated for 107 s), HeLa cells (irradiated for 121 s) and A549 cells (irradiated for 127 s) were 50%. LTP destroyed the ultrastructure of HepG2, A549 and HeLa cells to different degrees, showing nuclear fragmentation and organelle damages. The apoptosis rates of the three cell lines were increased at 24 h after exposure to LTP for 1/6 IC50 irradiation time. Furthermore, LTP irradiation also suppressed the protein expression of Bcl-2 and XRCC1 and increased that of Bax. Conclusions: LTP has an obvious killing effect on HepG2, A549 and HeLa cancer cell lines. This effect may be related to the induction of cell apoptosis and inhibition of DNA repair.
Collapse
Affiliation(s)
- L L Wang
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - S B Qin
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - X T Xu
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - C Hu
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - D Q Qian
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - C Ye
- Department of Physics, Optoelectronics and Energy, Soochow University, Suzhou 215006, China
| | - J Y Zhou
- Deparment of Radiation Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| |
Collapse
|